Home
>
US Stocks
>
Precision Biosciences Inc
Precision Biosciences Inc
DTIL

Precision Biosciences Inc (DTIL)

$4.597.65%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$4.87
Today Low/High$4.54 / $4.87
52 Week Low/High$4.52 / $15.98
Market Cap$360.96M

Company Details

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
OrganisationPrecision Biosciences Inc
HeadquatersDurham, North Carolina, United States
IndustryBiotechnology
CEOMatthew Kane

Discover more

Frequently Asked Questions

What is Precision Biosciences Inc (DTIL) share price today?

Can Indians buy Precision Biosciences Inc (DTIL) shares?

How can I buy Precision Biosciences Inc (DTIL) shares from India?

Can Fractional shares of Precision Biosciences Inc (DTIL) be purchased?

What are the documents required to start investing in Precision Biosciences Inc (DTIL) stocks?